GtoPdb is requesting financial support from commercial users. Please see our sustainability page for more information.
| 
                                                                Synonyms: compound A  [WO2023149450A1] | CTX-177 | CTX177
                                 Compound class: 
                                                            Synthetic organic
                                 
                                    
                                        Comment: The chemical structure for ocipumaltib was included in WHO INN proposed list 133 (10th July 2025). It is one of the compounds claimed as MALT1 paracaspase inhibitors in patent WO2023149450A1 [1], making this likely to be the INN for Chordia Therapeutics' clinical lead CTX-177. MALT1 is a therapeutic target for the treatment of lymphomas in which the protein is aberrantly activated.
                                    
                                 | 
 | |||||||||||||||||||||||||||||||||||
| Classification  | |
| Compound class | Synthetic organic | 
| IUPAC Name  | 
| 1-[6-chloro-4-[(1S)-1-methoxyethyl]-1,5-naphthyridin-3-yl]-3-[6-(triazol-2-yl)-5-(trifluoromethyl)pyridin-3-yl]urea | 
| International Nonproprietary Names  | |
| INN number | INN | 
| 13582 | ocipumaltib | 
| Synonyms  | 
| compound A [WO2023149450A1] | CTX-177 | CTX177 | 
| Database Links  | |
| GtoPdb PubChem SID | 518520677 | 
| PubChem CID | 151085091 | 
| Search Google for chemical match using the InChIKey | MKYDKGUTYKFCHS-JTQLQIEISA-N | 
| Search Google for chemicals with the same backbone | MKYDKGUTYKFCHS | 
| Search PubMed clinical trials | ocipumaltib | 
| Search PubMed titles | ocipumaltib | 
| Search PubMed titles/abstracts | ocipumaltib | 
| UniChem Compound Search for chemical match using the InChIKey | MKYDKGUTYKFCHS-JTQLQIEISA-N | 
| UniChem Connectivity Search for chemical match using the InChIKey | MKYDKGUTYKFCHS-JTQLQIEISA-N |